H.C. Wainwright Maintains Palvella Therapeutics(PVLA.US) With Buy Rating, Maintains Target Price $38

Moomoo NewsJan 3 06:31 ET · Ratings

Palvella Therapeutics Registers 5.6M Shares by Selling Holders

Seeking AlphaDec 31, 2024 06:21 ET

H.C. Wainwright Initiates Palvella Therapeutics(PVLA.US) With Buy Rating, Announces Target Price $38

Moomoo NewsDec 26, 2024 06:32 ET · Ratings

Palvella Therapeutics Price Target Announced at $38.00/Share by HC Wainwright & Co.

Dow JonesDec 26, 2024 06:25 ET · Ratings

Optimistic Buy Rating for Palvella Therapeutics' QTORIN Gel Due to Unmet Need and Market Potential

TipRanksDec 26, 2024 06:15 ET · Ratings

Palvella Therapeutics Analyst Ratings

BenzingaDec 26, 2024 06:12 ET · Ratings